By 2030, it is anticipated that the Nigeria Lung Cancer Therapeutics Market will reach a value of $54 Mn from $27 Mn in 2022, growing at a CAGR of 9.1% during 2022-30. The Lung Cancer Therapeutics Market in Nigeria is dominated by a few domestic pharmaceutical companies such as Neimeth International Pharmaceuticals, Fidson Healthcare Plc, and Swiss Pharma Nigeria Limited. The Lung Cancer Therapeutics Market in Nigeria is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Nigeria lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
By 2030, it is anticipated that the Nigeria Lung Cancer Therapeutics market will reach a value of $54 Mn from $27 Mn in 2022, growing at a CAGR of 9.1% during 2022-30.
Nigeria is a lower middle-income, developing country located in West Africa with a coast on the Gulf of Guinea and the Atlantic Ocean. Lung cancer is a public health concern that imposes a significant socioeconomic and disease burden on the West African sub-region, particularly Nigeria. Lung cancer ranks 14th on the list of newly diagnosed cancers in Nigeria, with a 1.4 % incidence. Exposure to petroleum, gas fumes products, and cement dust at construction sites is frequent among Nigerian urban inhabitants, and the usage of protective air filter masks is non-existent, creating a fertile field for researchers to investigate work-related linked risks of lung cancer.
According to the latest WHO data published in 2020 Lung Cancers Deaths in Nigeria reached 1,295 or 0.09% of total deaths. The age-adjusted Death Rate is 1.37 per 100,000 population ranks Nigeria 178th in the world. Nigeria's government spends 3.4% of its GDP on healthcare.
Market Growth Drivers
There has been an increase in awareness initiatives about lung cancer in Nigeria. Campaigns have been developed by organisations such as the Nigerian Cancer Society and the Lagos State University Teaching Hospital to educate the public on the risk factors, symptoms, and prevention of lung cancer. A well-coordinated and regularly monitored awareness and education campaign championed by the Nigerian Thoracic Society and comparable national groups throughout the West African subregion could be an excellent idea in Nigeria. These aspects could boost Nigeria's Lung Cancer Therapeutics market.
Market Restraints
In Nigeria or any other West African country, there is no well-coordinated lung cancer registry. Although operational, the Nigerian National System of Cancer Registries is nevertheless restricted in capacity due to logistical, legal, and sporadic financial issues. In Nigeria, people are generally unaware of the early warning symptoms and risk factors for lung cancer. In 2013, Nigeria had only nine cancer treatment clinics with radiotherapy facilities, despite a population of 172 Mn people, the majority of which were closed. With only four active cancer radiation facilities in 2020, the situation hasn't altered much. These factors may deter new entrants into the Nigeria Lung Cancer Therapeutics market.
Key Players
The National Agency for Food and Drug Administration and Control (NAFDAC), the National Drug Law Enforcement Agency (NDLEA), and the Federal Ministry of Health are the regulatory authorities in Nigeria with jurisdiction over medications, biologicals, and medical devices. In Nigeria, there is currently no established structure in place for drug price regulation or reimbursement of pharmaceuticals, biologicals, and medical devices.
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Type (Revenue, USD Billion):
By Therapy (Revenue, USD Billion):
By Type of Molecule (Revenue, USD Billion):
By Drug Class (Revenue, USD Billion):
By Distribution Channel (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
Need more?